🔴 Nasus Pharma is trading 5% down today

Nasus Pharma is trading at $3.35, down -5.10%, with no reliable catalyst currently explaining the decline.

• No company-specific headlines were reported for September 21, 2026, according to available market coverage.
• The broader market is rising, so today’s positive global risk sentiment does not clearly explain the decline.
• Nasus Pharma’s FDA clearance announcement for NS002 was published on September 14, 2026, making it prior context rather than a fresh catalyst.